SocialyTime SocialyTime
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher
    Mode nuit

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Blogs
  • Offres
  • Emplois
  • Courses
  • Articles
  • Blogs
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • Deng Yue Ajouter une nouvelle offre d'emploi Fitness
    2026-01-13 09:57:35 -
    Say goodbye to the era of "high doses"! How does Tenofovir Amibufenamide achieve highly effective antiviral effects with only 1/10 of the dose?
    01/13/2026 Written by DengyueMed Tenofovir Amibufenamide (Hengmu®) is a next-generation tenofovir prodrug independently developed in China for the treatment of chronic hepatitis B (CHB). Designed with optimized molecular structure and enhanced liver targeting, Tenofovir Amibufenamide delivers potent antiviral efficacy at a significantly lower dose, while offering a favorable long-term...
    0 Commentaires 0 Parts 345 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Shweta Kadam Ajouter une nouvelle offre d'emploi Autre
    2025-12-16 11:07:19 -
    Eastern Equine Encephalitis Market Size, Analysis, Scope, Demand, Opportunities, Statistics
    "Executive Summary Eastern Equine Encephalitis Market Size and Share Forecast The global eastern equine encephalitis market size was valued at USD 150.5 billion in 2025 and is expected to reach USD 391.67 billion by 2033, at a CAGR of 12.70 % during the forecast period. All the data and information involved in this Eastern Equine Encephalitis report has...
    0 Commentaires 0 Parts 746 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
  • Amit Sharma Ajouter une nouvelle offre d'emploi Autre
    2025-12-04 13:03:06 -
    Remdesivir Production Cost Analysis Report by Procurement Resource
    Procurement Resource, a leading name in procurement intelligence and market research, is pleased to release its latest Remdesivir Production Cost Report. This detailed report is a crucial tool for pharmaceutical companies, active pharmaceutical ingredient (API) manufacturers, investors, and regulatory stakeholders seeking to gain a deep understanding of the economics, technologies, and market...
    0 Commentaires 0 Parts 547 Vue 0 Aperçu
    Connectez-vous pour aimer, partager et commenter!
© 2026 SocialyTime French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Environ Conditions générale de vente Confidentialité Contactez nous Annuaire